細胞膜透過ペプチドの世界市場：タイプ別、用途別、エンドユーザー別、地域別

細胞膜透過ペプチドの世界市場は、2025年には42億米ドルと推定され、2032年には121億6,000万米ドルに達すると予測され、2025年から2032年までのCAGRは16.4%で成長すると予測されます。

図.細胞膜透過ペプチドの世界市場シェア（%）、2025年地域別

細胞膜透過ペプチド（CPP）は、細胞膜を通過し、抗体、核酸、化学治療薬などの生物活性物質を細胞内に送達することができる短いアミノ酸配列です。障壁を通過するその能力は、様々な治験薬や承認された治療薬の送達を可能にする重要な分子トランスポーターとなっています。この市場では、安定性、溶解性、細胞への取り込み効率などの薬理学的特性を改善するために、細胞膜透過ペプチド（CPPs）の配列やコンジュゲーション技術を最適化する研究が盛んに行われています。がん、神経変性、慢性感染症などの疾患に対するCPPベースの市場開拓戦略開発への関心が高まる中、細胞浸透性ペプチド市場は今後急速なペースで成長すると予想されます。

CPPは、生理学的条件下で生細胞に非侵襲的、効率的、かつ迅速にカーゴ分子を送達するため、従来のトランスフェクション法にはない数多くの利点を提供します。分子結合が容易で生体適合性の高い取り込みが可能なことから、CPPはタンパク質治療、遺伝子導入、画像診断などの研究・治療用途に大きな可能性を秘めています。しかしながら、その非選択的な二重層破壊と高濃度での細胞毒性の可能性は、依然として大きな課題です。設計戦略の改善は、より安全で標的特異的なCPPの開発を目指しています。

市場力学：.

細胞膜透過ペプチド市場は、治療薬の細胞内デリバリーを必要とするがんなどの疾病の増加、研究開発の進展、製薬企業による投資、ペプチドベースの薬剤の採用拡大などが牽引しています。しかし、一部のCPPに関連する安定性の低さ、予測できない毒性、免疫反応の阻害といった課題が市場の成長を妨げています。無毒性で生体適合性の高い新世代のペプチド配列を開発するための継続的な研究が、大きなビジネスチャンスをもたらしています。

本調査の主な特徴

• 本レポートは、世界の細胞膜透過ペプチド市場を詳細に分析し、2024年を基準年とした予測期間（2025-2032年）の市場規模および年間平均成長率（CAGR%）を提供します。
• また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて説明しています。
• また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
• 企業ハイライト、製品ポートフォリオ、主要なハイライト、業績、戦略などのパラメータに基づいて、世界の細胞膜透過ペプチド市場の主要企業プロファイルを掲載しています。
• 本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品上市、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
• この調査レポートは、投資家、サプライヤー、製品メーカー、販売業者、新規参入者、財務アナリストなど、この業界のさまざまな利害関係者を対象としています。
• 利害関係者は、世界の細胞膜透過ペプチド市場を分析する際に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。

目次

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場の展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー
• Coherent Opportunity Map（COM）

第3章 市場力学、規制、動向分析

• 市場力学
• 影響分析
• 主なハイライト
• 規制シナリオ
• サービス提供ポートフォリオ
• PEST分析
• PORTERの分析
• 合併と買収のシナリオ
• パイプライン分析

第4章 世界の細胞膜透過ペプチド市場- コロナウイルス（COVID-19）パンデミックの影響

• COVID-19疫学
• 供給側と需要側の分析
• 経済への影響

第5章 世界の細胞膜透過ペプチド市場、タイプ別、2020年～2032年

• タンパク質由来CPP
• 合成CPP
• キメラCPP

第6章 世界の細胞膜透過ペプチド市場、用途別、2020年～2032年

• ドラッグデリバリー
• 遺伝子送達
• 診断
• 分子イメージング
• その他

第7章 世界の細胞膜透過ペプチド市場、エンドユーザー別、2020年～2032年

• バイオ医薬品企業
• 受託研究機関（CRO）/CDMO
• 病院と診療所
• その他

第8章 世界の細胞膜透過ペプチド市場、地域別、2020年～2032年

• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東
• アフリカ

第9章 競合情勢

• AnaSpec
• Peptomyc
• BioAlps
• Sarepta Therapeutics, Inc.
• REVANCE THERAPEUTICS
• PolyPeptide Group
• Bachem
• Pepscan
• Creative Peptides
• Cupidpeptides
• AltaBioscience Ltd

第10章 セクション

• 調査手法
• 出版社について

Global Cell Penetrating Peptide Market is estimated to be valued at USD 4.2 Bn in 2025 and is expected to reach USD 12.16 Bn by 2032, growing at a compound annual growth rate (CAGR) of 16.4% from 2025 to 2032.

Figure. Global Cell Penetrating Peptide Market Share (%), By Region 2025

Cell penetrating peptides (CPPs) are short sequences of amino acids that are able to cross cell membranes and deliver attached bioactive cargo such as antibodies, nucleic acids, and chemotherapeutics into cells. Their ability to traverse barriers has made them important molecular transporters, enabling the delivery of various investigational and approved therapeutics. The market has witnessed considerable research on optimizing Cell penetrating peptides (CPPs) sequences and conjugation techniques to improve pharmacological properties such as stability, solubility, and cellular uptake efficiency. With growing interest in developing CPP-based delivery strategies for diseases like cancer, neurodegeneration, and chronic infections, the cell penetrating peptide market is anticipated to grow at a rapid pace in the future.

CPPs offer numerous advantages over traditional transfection methods as they provide a non-invasive, efficient, and rapid delivery of cargo molecules into live cells under physiological conditions. Given their easy molecular conjugation and biocompatible uptake, CPPs hold immense potential for research and therapeutic applications including protein therapy, gene delivery, and diagnostic imaging. However, their non-selective bilayer disruption and possible cytotoxicity at higher concentrations remain major challenges. Improved design strategies aim to develop safer and more target-specific CPPs.

Market Dynamics:

The cell penetrating peptide market is driven by rising incidences of diseases such as cancer and others requiring intracellular delivery of therapeutics, increasing research and development, investments by pharmaceutical companies, and growing adoption of peptide-based drugs. However, challenges pertaining to poor stability, unpredictable toxicity, and immune response inhibition associated with some CPPs hamper market growth. Ongoing research to engineer newer generations of non-toxic and biocompatible peptide sequences presents significant opportunities.

Key features of the study:

• This report provides in-depth analysis of the global cell penetrating peptide market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global cell penetrating peptide market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include AnaSpec, Peptomyc, BioAlps, Sarepta Therapeutics, Inc., REVANCE THERAPEUTICS, PolyPeptide Group, Bachem, Pepscan Creative Peptides, Cupidpeptides and AltaBioscience Ltd
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global cell penetrating peptide market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell penetrating peptide market

Detailed Segmentation:

• Global Cell Penetrating Peptide Market, By Type
  • Protein Derived CPPs
  • Synthetic CPPs
  • Chimeric CPPs
• Global Cell Penetrating Peptide Market, By Application
  • Drug Delivery
  • Gene Delivery
  • Diagnostics
  • Molecular Imaging
  • Others
• Global Cell Penetrating Peptide Market, By End User
  • Biopharmaceutical Companies
  • Contract Research Organization (CROs)/CDMO
  • Hospitals and Clinics
  • Others
• Global Cell Penetrating Peptide Market, By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
• Company Profiles
  • AnaSpec
  • Peptomyc
  • BioAlps
  • Sarepta Therapeutics, Inc.
  • REVANCE THERAPEUTICS
  • PolyPeptide Group
  • Bachem
  • Pepscan
  • Creative Peptides
  • Cupidpeptides
  • AltaBioscience Ltd

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Cell Penetrating Peptide Market, By Type
  • Global Cell Penetrating Peptide Market, By Application
  • Global Cell Penetrating Peptide Market, By End User
  • Global Cell Penetrating Peptide Market, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Expanding Applications in Regenerative Medicine
  • Low drug encapsulation efficiency
  • Increasing applications of CPPs in therapeutics development
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Service offering Portfolio
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Pipeline Analysis

4. Global Cell Penetrating Peptide Market- Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Cell Penetrating Peptide Market, By Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Protein Derived CPPs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Synthetic CPPs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Chimeric CPPs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Cell Penetrating Peptide Market, By Application, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Drug Delivery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Gene Delivery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Diagnostics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Molecular Imaging
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Cell Penetrating Peptide Market, By End User, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Biopharmaceutical Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Contract Research Organization (CROs)/CDMO
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Hospitals and Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Cell Penetrating Peptide Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Country, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Country 2021 -2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• AnaSpec
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Peptomyc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• BioAlps
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Sarepta Therapeutics, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• REVANCE THERAPEUTICS
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• PolyPeptide Group
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Strategies
• Bachem
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Pepscan
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Creative Peptides
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Cupidpeptides
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• AltaBioscience Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us